EFFICACY AND SAFETY OF VEDOLIZUMAB FOR INDUCTION OF REMISSION IN INFLAMMATORY BOWEL DISEASE- THE ISRAELI EXPERIENCE.
Uri Kopylov 1
Yulia Ron 2
Irit Avni-Biron 3
Benjamin Koslovsky 4
Mattitiahu Waterman 5
Salech Daher
Bella Ungar
Henit Yanai
Nitsan Maharshak
Ofer Ben-Bassat
Lev Lichtenstein
Ariella Bar Gil Shitrit
Eran Israeli
Abraham (Rami) Eliakim
Yehuda Chowers
Shomron Ben-Horin
Iris Dotan
1 CHAIM SHEBA MEDICAL CENTER RAMAT GAN ISRAEL, gastroenterology, Ramat Gan, Israel
2 Tel Aviv Sourasky Medical Center, 2-IBD Center, Department of Gastroenterology and Liver Diseases, Tel Aviv, Israel
3 Rabin Medical Center, Gastroenterology, Petach Tikva, Israel
4 Shaare Zedek Medical Center, Gastroenterology, Jerusalem, Israel
5 Rambam Hea
Conference
UEG Week 2016
Citation
United European Gastroenterology Journal; 2016: 2 (Supplement 1)
Login to access library content
Do you need help setting up your myUEG account?
Contact us at [email protected]